Blog - Healthware Group

BlogPost

Digital health and pharma – adapting to the post-coronavirus paradigm

The need for digital transformation and a response model for COVID-19 were among the topics discussed in a recent digital debate

Digital health in a post-Covid world

Our CEO & Founder, Roberto Ascione, discusses the impact of the Coronavirus emergency on the acceleration of the digital health in this conversation with Attilio Mazzilli, Head of Orrick’s Italian Tech Group.

Point of view

COVID-19 and Its Impact on Patient Support Programs

COVID-19 has upended our healthcare system and thrust pharmaceutical product patient support programs (PSPs) onto the front lines of treatment management.

7/05/2020 | BlogPost

Virtual medical conference insights #Covid19

COVID-19 has fundamentally changed how we deliver conferences in 2020

6/05/2020 | Point of view

Impact of COVID-19 on Clinical Trials

The social-distancing restrictions of the COVID-19 pandemic, in addition to the redirection of hospital resources, may pose extensive burdens on clinical trials.

23/04/2020 | BlogPost

Capitalizing on the potential of digital therapeutics during this health emergency

The ongoing global health crisis due to the coronavirus pandemic is going to have a lasting impact on all of our lives. A recent article in Forbes goes in depth on these topics, talking about the positive impact that DTx can have on fragile patients, physicians and health systems’ sustainability